From 27 November 2026, MDMB-FUBINACA, a synthetic cannabinoid receptor agonist, will be controlled as a dangerous drug along with two synthetic opioids. The order was gazetted on 2 October 2026 and tabled for negative vetting; the government said no abuse case had yet been detected in Hong Kong. The listing follows the UN Commission on Narcotic Drugs' March 2026 decision to place the three substances under international control.[1][2]
Listed for context. No score change is recorded for Hong Kong here.
References
- Hong Kong Security Bureau — Legislative Council brief on the Dangerous Drugs Ordinance (Amendment of First Schedule) Order 2026Paragraphs 1–6: three substances, UN control decision, gazettal 2 October 2026, commencement 27 November 2026
- Hong Kong Government — Order to amend Dangerous Drugs Ordinance to be gazetted on October 2, 30 September 2026Three substances; expected effective date 27 November 2026
Checked. The date and the event were compared with a source that was read.